Manulife (Manufacturers Life Insurance)’s Rhythm Pharmaceuticals RYTM Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $4.31M | Buy |
68,132
+3,746
| +6% | +$237K | ﹤0.01% | 1230 |
|
2025
Q1 | $3.41M | Buy |
64,386
+4,417
| +7% | +$234K | ﹤0.01% | 1304 |
|
2024
Q4 | $3.36M | Buy |
59,969
+11,266
| +23% | +$631K | ﹤0.01% | 1359 |
|
2024
Q3 | $2.55M | Sell |
48,703
-588
| -1% | -$30.8K | ﹤0.01% | 1470 |
|
2024
Q2 | $2.02M | Buy |
49,291
+1,667
| +4% | +$68.4K | ﹤0.01% | 1492 |
|
2024
Q1 | $2.06M | Buy |
47,624
+8,386
| +21% | +$363K | ﹤0.01% | 1504 |
|
2023
Q4 | $1.8M | Buy |
39,238
+19,075
| +95% | +$877K | ﹤0.01% | 1503 |
|
2023
Q3 | $462K | Sell |
20,163
-743
| -4% | -$17K | ﹤0.01% | 2174 |
|
2023
Q2 | $345K | Buy |
+20,906
| New | +$345K | ﹤0.01% | 2266 |
|
2022
Q2 | – | Sell |
-19,385
| Closed | -$223K | – | 3123 |
|
2022
Q1 | $223K | Sell |
19,385
-5,310
| -22% | -$61.2K | ﹤0.01% | 2698 |
|
2021
Q4 | $246 | Buy |
24,695
+272
| +1% | +$3 | ﹤0.01% | 2763 |
|
2021
Q3 | $319K | Sell |
24,423
-1,285
| -5% | -$16.8K | ﹤0.01% | 2621 |
|
2021
Q2 | $503K | Buy |
25,708
+3,686
| +17% | +$72.1K | ﹤0.01% | 2427 |
|
2021
Q1 | $468K | Buy |
22,022
+1,728
| +9% | +$36.7K | ﹤0.01% | 2322 |
|
2020
Q4 | $603K | Buy |
20,294
+369
| +2% | +$11K | ﹤0.01% | 2089 |
|
2020
Q3 | $432K | Sell |
19,925
-437
| -2% | -$9.48K | ﹤0.01% | 2070 |
|
2020
Q2 | $444K | Buy |
20,362
+1,134
| +6% | +$24.7K | ﹤0.01% | 2032 |
|
2020
Q1 | $293K | Buy |
19,228
+4,777
| +33% | +$72.8K | ﹤0.01% | 2105 |
|
2019
Q4 | $332K | Sell |
14,451
-625
| -4% | -$14.4K | ﹤0.01% | 2276 |
|
2019
Q3 | $319K | Sell |
15,076
-30
| -0.2% | -$635 | ﹤0.01% | 2285 |
|
2019
Q2 | $332K | Buy |
+15,106
| New | +$332K | ﹤0.01% | 2300 |
|
2018
Q3 | – | Sell |
-10,017
| Closed | -$314K | – | 3717 |
|
2018
Q2 | $314K | Buy |
10,017
+2,749
| +38% | +$86.2K | ﹤0.01% | 2746 |
|
2018
Q1 | $145K | Buy |
7,268
+950
| +15% | +$19K | ﹤0.01% | 3256 |
|
2017
Q4 | $184K | Buy |
+6,318
| New | +$184K | ﹤0.01% | 3069 |
|